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Abstract 
The present study investigated if and to what extent murine stem cell-derived beating 
cardiomyocytes within embryoid bodies can be used as a broad screening in vitro assay for 
neurotoxicity testing, replacing for example in vivo tests for marine neurotoxins. Effect of nine 
model compounds, acting on either the Na+, K+, or Ca2+ channels or the Na+/K+-ATPase pump, 
on the beating was assessed. Diphenhydramine, veratridine, isradipine, verapamil and ouabain 
induced specific beating arrests that were reversible and none of the concentrations tested 
induced cytotoxicity. Three K+ channel blockers, amiodarone, clofilium and sematilide, and the 
Na+/K+-ATPase pump inhibitor digoxin had no specific effect on the beating. In addition, two 
marine neurotoxins i.e. saxitoxin and tetrodotoxin elicited specific beating arrests in 
cardiomyocytes. Comparison of the results obtained with cardiomyocytes to those obtained with 
the neuroblastoma neuro-2a assay revealed that the cardiomyocytes were generally somewhat 
more sensitive for the model compounds affecting Na+ and Ca2+ channels, but less sensitive for 
the compounds affecting K+ channels. The stem cell-derived cardiomyocytes were not as 
sensitive as the neuroblastoma neuro-2a assay for saxitoxin and tetrodotoxin. It is concluded that 
the murine stem cell-derived beating cardiomyocytes provide a sensitive model for detection of 
specific neurotoxins and that the neuroblastoma neuro-2a assay may be a more promising cell-
based assay for the screening of marine biotoxins. 
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Introduction 
During the last two decades, the in vitro embryonic stem cell test (EST), in which murine D3 
cells are induced to differentiate into beating cardiomyocytes formed in attached embryoid 
bodies (EBs), has been successfully implemented and validated by the European Centre for the 
Validation of Alternative Methods (ECVAM) for the assessment of embryo toxicity [1]. Where 
embryo toxicity is assessed by the effect of a compound on the differentiation process, the 
present study uses the beating cardiomyocytes within EBs as a model to study effects of 
neurotoxic compounds. The mechanism behind the contractions of the cardiomyocytes involves 
Na+, Ca2+, K+ channels and the Na+/K+-ATPase pump. These channels and pump are also 
involved in the generation of the action potential in neuronal cells and are important for a wide 
range of physiological processes, including intracellular messaging, regulation of cell volume, 
regulation of gene expression, synaptic transmission, and cardiac excitation-contraction coupling 
[2]. The blockade or opening of these ion channels results in a disturbance of the ion homeostasis 
that in turn affects the physiology and action potentials of the cells. Figure 4.1 describes which 
channels are involved in the generation of action potentials both in cardiac and neuronal cells [3]. 
Although action potentials in the heart (both in pacemaker cells and in cardiomyocytes) and 
neurons are driven by similar ionic fluxes (Na+, K+ and Ca2+), different ion channel subtypes 
exist, resulting in different specificity and sensitivity towards different neurotoxins [4]. However, 
despite the differences, murine embryonic stem cell-derived beating cardiomyocytes might be a 
promising model for the detection of neurotoxic compounds, including marine neurotoxins, 
because Na+, Ca2+ and K+ channels and the Na+/K+-ATPase pump are the target of a wide range 
of neurotoxic compounds [5-7]. Marine biotoxins are naturally occurring chemicals produced by 
microscopic algae. They accumulate in fish and shellfish and therefore represent a threat for 
consumers. The current standard for the detection of marine biotoxins in seafood is the in vivo 
mouse bioassay (MBA), in which mice are injected with sample extracts and death is the final 
readout. More recently, a chemical analytical LC/MS-MS method was EU approved/accepted 
but many countries still use the MBA, as the chemical analysis method is not able to detect all 
known toxins and misses unknown toxins. Extensive information on marine biotoxins can be 
found in recent reviews [8, 9]. In line with the 3R concept of Russell and Burch, alternative in 
vitro assays to replace in vivo testing are urgently needed as in vivo tests are considered as 
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highly unethical [10]. In the case of marine biotoxins, the mouse test will be forbidden from 
2015 onwards, except for the control of production areas where seafood produced is intended for 
future consumption [11]. 
 
Figure 4.1: Overview of ion channels and fluxes involved in the generation of action potentials in 
A) neuronal cells and B) cardiomyocytes (based on [2, 3]). A) A stimulus increases the 
membrane potential above the excitation threshold until +40 mV thanks to Na+ influx. At +40 
mV an efflux of K+ ions brings the membrane potential back to -70 mV. B) K+ and Na+ influxes 
raise the membrane potential from -70 to +20 mV. Na+ channels close and L-type Ca2+ 
channels open, causing a plateau. K+ channels open decreasing the membrane potential back to 
its initial value of -70 mV. 
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Maltsev et al. (1994) showed that all basic cardiac-specific channels are present in murine 
embryonic stem cell-derived cardiomyocytes [12]. Since neurons and cardiomyocytes share 
many ion channels [13] and a wide range of neurotoxic compounds are known to act on ion 
channels, we hypothesized that beating cardiomyocytes might be suitable as an in vitro tool to 
detect the potential neurotoxic effects of compounds, including marine neurotoxins. Based on 
these considerations the aim of the present study was to assess whether and to what extent 
embryonic stem cell-derived cardiomyocytes could be used as an in vitro assay for the screening 
of neurotoxic compounds. To this end cardiomyocytes formed in EBs were exposed to different 
neurotoxins, using the contractility (i.e. the inotropy) of the cardiomyocytes within the EBs as a 
read-out. Nine model neurotoxins were selected that are known to affect either one of the three 
types of channels or the Na+/K+-ATPase pump (Tab. 4.1). In addition to these nine model 
neurotoxins, two commercially available pure marine neurotoxins were tested: saxitoxin (STX) 
and tetrodotoxin (TTX) (Na+ channel blockers) in order to establish whether this assay may be of 
value as a replacement of the in vivo assays currently used for the screening of marine biotoxins 
in seafood. Moreover, the nine model compounds and STX and TTX were also tested in the 
neuroblastoma neuro-2a assay in order to compare the sensitivity of the embryonic stem cell-
derived cardiomyocytes to the sensitivity of the neuro-2a cells, as the latter is currently regarded 
as a promising cell-based assay for the screening of marine biotoxins in seafood [8, 14]. 
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Table 4.1. Inhibition of beatings in contractile embryonic stem cell-derived cardiomyocytes and 
effect on the viability in the neuro-2a assay. 
aThe references stand for the modes of action of the selected model compounds and the EC50 
values are mentioned when available. bThe percentage of cell viability was determined at 
concentrations above those which elicited effects on beatings of cardiomyocytes following a 24 
hour exposure to the compounds. cThe EC50 values were calculated using a non-linear regression 
model. o/v: ouabain/veratridine. 
Compound Mode of action Referencesa % cell viability at the 
noted drug 
concentration 
(differentiated 
  
EC50 
differentiated 
cardiomyocytesc 
EC50 
neuro-2ac 
Diphenhydramine Na+ channel 
blocker 
[15, 16] 150 µM: 104 ± 14 45 µM  > 100 µM 
Veratridine Na+ channel 
opener 
[17, 18] (EC50: 
85 µM) 
100 µM: 114 ± 6 35 µM  90 µM 
Isradipine Ca2+ channel 
blocker 
[19] 100 µM: 113 ± 23 15 µM  > 100 µM 
Verapamil Ca2+ channel 
blocker 
[20, 21] (EC50: 
19 µM) 
 
1 µM: 106 ± 10 100 nM  190 nM 
Sematilide K+ channel 
blocker 
[22] 500 µM: 95 ± 10 > 400 µM > 300 µM 
Clofilium K+ channel 
blocker 
[23] 500 µM: 51 ± 0.25 207 µM due to 
cytotoxicity 
150 µM 
Amiodarone K+ channel 
blocker 
[24] 60 µM: 54 ± 1 > 60 µM 80 µM 
Ouabain Na+/K+ ATPase 
blocker 
[25] (EC50: 
370 µM) 
600 µM: 86 ± 4 257 µM  220 µM 
Digoxin Na+/K+ ATPase 
inhibitor 
[26] 160 µM: 64 ± 4 > 150 µM > 100 µM 
Saxitoxin Na+ channel 
blocker 
[27] No cytotoxicity up to 1 
µM 
4 µM 
 
With o/v: 
11 nM 
Tetrodotoxin Na+ channel 
blocker 
[28] No cytotoxicity up to 10 
µM 
10 µM (with 
veratridine) 
 
With o/v: 
10 nM 
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Materials and Methods 
Chemicals 
Amiodarone, clofilium, digoxin, diphenhydramine, isradipine, ouabain, sematilide, verapamil, 
and veratridine were purchased from Sigma-Aldrich (St. Louis, USA) and dimethylsulfoxide 
(DMSO) was obtained from Acros Organic (New Jersey, USA). STX was purchased from the 
National Research Council (Montreal, Canada) and TTX from Latoxan (Valence, France). 
Compound stock solutions were prepared in DMSO. 
Cell lines and cell culture 
The murine-derived embryonic stem cell line D3 was kindly donated by Johnson & Johnson 
(Beerse, Belgium). The cells were cultured in flasks of 25 cm2 (Corning Inc., Cambridge, USA) 
in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Breda, The Netherlands) 
supplemented with 20% (v/v) heat inactivated fetal calf serum (FCS) (BioWhittaker, Maryland, 
USA), 1% (v/v) non-essential amino acids (Invitrogen), 50 U/mL penicillin/50 µg/mL 
streptomycin (P/S) (Invitrogen), 2 mM L-glutamine (Invitrogen) and 0.1 mM ß-mercaptoethanol 
(Sigma-Aldrich). To prevent cell differentiation, 1000 U/mL murine leukemia inhibitory factor 
(Sigma-Aldrich) was added to the medium when cells were seeded. The cells were cultured in a 
humidified atmosphere (37°C, 5% CO2) and subcultured three times a week. The cells were 
detached when reaching 80% confluence using non-enzymatic dissociation buffer (Sigma-
Aldrich). 
Neuro-2a cells (LGC standards, Middlesex, UK) were cultured in flasks of 75 cm2 using 10% 
FBS/Roswell Park Memorial Institute medium (RPMI-1640) supplemented with 1% 5000 U/mL 
penicillin/5 mg/mL streptomycin (P/S) (Invitrogen), 2 mM L-glutamine (Invitrogen) and 1 mM 
sodium pyruvate (Sigma-Aldrich). Cells were cultured at 37°C, 5% CO2 and subcultured 3 times 
per week. The cells were detached when reaching 80% confluence using trypsin (Sigma-
Aldrich). 
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Embryonic stem cell test 
The embryonic stem cell test was performed as described previously [29] with some minor 
modifications. For the differentiation process, hanging drops of 20 µl cell suspension (3.75.104 
cells/mL) were prepared at day 0 on the cover of 96-well plates. Phosphate buffered saline (250 
µL) was put in each well in order to maintain humidity and prevent evaporation of the hanging 
drops. Cells in hanging drops were allowed to differentiate for 3 days in the humidified 
atmosphere (37°C, 5% CO2), and at day 3, the cell aggregates formed (called EBs) were 
transferred to bacterial petri dishes (Greiner Bio-one, Alphen a/d Rijn, The Netherlands) and 
incubated for 3 days. At day 5, the EBs were plated in 96-well plates (Corning, 1 EB/well) and 
incubated for 5 days. The cardiomyocytes started beating on day 10. 
At day 13, when most EBs have beating areas, beating EBs were incubated with the 
neurotoxic compounds for 1 h (37°C, 5% CO2). Ten beating EBs per concentration were exposed 
to the different compounds selected (final DMSO solvent concentration of 0.25%) and the 
number of remaining beating EBs after one hour incubation was scored by visual inspection 
(beating arrest). Subsequently, cells were washed and the medium was replaced by medium 
without the test compound, and the EBs were incubated for an additional hour after which the 
contractility of the EBs was assessed again to evaluate recovery. At least three independent 
experiments with six replicates were performed per concentration for each compound. In the case 
of STX, five instead of ten EBs were exposed and the number of beating EBs were scored after 
20 hours of incubation instead of one hour. The control for STX was a solution of HCl (0.003 M) 
as commercial STX is dissolved in HCl. Because TTX alone did not affect the beatings and 
TTX, being a sodium channel blocker, has an opposite mode of action as veratridine which acts 
as a sodium channel activator, two experimental designs were tested to evaluate whether TTX 
could prevent beating arrest following veratridine exposure: ten EBs were exposed to 10 µM of 
TTX for 5 minutes and then exposed to 100 µM of veratridine for one hour and in another 
experiment, ten EBs were exposed to 100 µM of veratridine for 1 h followed by an exposure to 
10 µM of TTX for an additional hour. 
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Cell viability  
Cell viability was assessed with the WST-1 assay by measuring mitochondrial activity (Roche, 
Woerden, The Netherlands) for embryonic stem cell-derived cardiomyocytes. The viability of 
the cardiomyocytes within EBs was assessed 24 hours after exposure to the different compounds 
and vehicle. To this end, 20 µL of WST-1 solution was added to each well containing 200 µL of 
medium. After incubation for 3 h (37°C, 5% CO2), the absorbance was determined 
spectrophotometrically at 450 nm. The mitochondrial activity was expressed as percentage of the 
average of the vehicle control (DMSO solvent). 
Neuro-2a assay 
Cells were grown for 24 hours and subsequently exposed for 24 hours to the marine neurotoxins 
with and without a combination of ouabain/veratridine. Concentrations of ouabain/veratridine 
inducing about 80% cytotoxicity were selected, in order to evaluate the toxin’s ability to oppose 
or prevent the cytotoxicity induced by this Na+ channel opener (veratridine) and Na+/K+-ATPase 
pump blocker (ouabain). Cell viability of neuro-2a cells was assessed with the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich) measuring 
the mitochondrial activity. Absorbance was read on a spectrophotometer at 570 nm and the 
mitochondrial activity was expressed as percentage of the average of the vehicle control 
(DMSO). 
Data analysis 
In this study, the EC50 of a compound is the concentration at which 50% of the maximum 
inhibiting effect on the contractility of the cardiomyocytes was induced. The EC50 values and 
their 95% confidence intervals (CI) were calculated using GraphPad Prism (San Diego, CA). 
When no inhibition of the contractility occurred, no EC50 value could be calculated (Tab. 4.1). 
For the establishment of dose-response curves and the determination of EC50 values for the 
neuro-2a assay, cell viability for each concentration of each model compound or marine 
neurotoxin after a 24 hour exposure was measured at least in duplicate. In this assay, the EC50 is 
the concentration at which 50% of the cytotoxicity occurs following exposure to the model 
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compounds and the concentration at which 50% of the cytotoxic effect caused by 
ouabain/veratridine is opposed following exposure to the marine neurotoxins. 
 
Results 
With the embryonic stem cell test (EST), the proportion of beating EBs is the read-out and cell 
viability was assessed by the WST-1 assay as the MTT yielded unreliable results (due to loss of 
cells during the removal of the medium), while in the neuro-2a assay, the cell viability is the 
read-out and was assessed by the MTT assay as the neuro-2a cells were well attached to the 
bottom of each well. Moreover, in the neuro-2a MTT assay, STX and TTX and the nine 
neurotoxic model compounds were also tested in combination with a dose of ouabain/veratridine 
that caused a 80% decrease in cell viability in order to determine whether the toxin was able to 
oppose the effect, i.e. to counteract the cytotoxicity induced by ouabain/veratridine [14]. 
However, none of the nine neurotoxic model compounds was able to oppose the cytotoxicity 
induced by ouabain/veratridine, and these results are not further discussed or shown. 
Na+ channels 
The Na+ channel blocker diphenhydramine inhibited beating of cardiomyocytes at and above a 
concentration of 25 µM (EC50 = 45 µM, Tab. 4.1). A concentration of 100 µM elicited beating 
arrests of all EBs (Fig. 4.2A). This beating arrest was completely reversible, as upon refreshing 
the medium, all EBs started to beat again. Veratridine induced a concentration-dependent 
decrease of the proportion of beating EBs at concentrations at and higher than 25 µM (EC50 = 35 
µM, Tab. 4.1). When the cells were exposed to 60 and 100 µM, all EBs stopped beating. After a 
recovery period of 1 h, every EB that stopped beating after exposure to 60 µM of veratridine 
started beating again, while for 100 µM 80% of the EBs recovered (Fig. 4.2B). The cell viability 
was not affected by both compounds according to the results obtained with the WST-1 assay 
(Tab. 4.1). 
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Figure 4.2: Effect of A) the Na+ channel blocker diphenhydramine, B) the Na+ channel opener 
veratridine, C-D) the Ca2+ channel blockers isradipine and verapamil, E-F) the Na+/K+-ATPase 
blockers ouabain and digoxin, G) the Na+ channel blocker STX, H-I-J) the K+ channel blockers 
amiodarone, clofilium and sematilide on the beating of embryonic stem cell-derived 
cardiomyocytes. Upon exposure the EBs were incubated with fresh medium for an additional 
hour to assess the recovery. The data are presented as the mean of 3 experiments ± SD. 0.3% 
DMSO or HCl, used as solvent controls, had no effect on cell viability. At least three 
independent experiments with ten replicates were performed per concentration for each 
compound. 
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Figure 4.3A and 4.3B show that in the neuro-2a assay, diphenhydramine slightly decreased cell 
viability while veratridine induced a concentration-dependent decrease in cell viability (EC50 = 
90 µM, Tab. 4.1).  
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Figure 4.3: Effect of A) the Na+ channel blocker diphenhydramine, B) the Na+ channel opener 
veratridine, C-D) the Ca2+ channel blockers isradipine and verapamil, E-F) the Na+/K+-ATPase 
blockers ouabain and digoxin, G-H-I) the K+ channel blockers amiodarone, clofilium and 
sematilide on the cell viability of neuro-2a cells. The cells were exposed for 24 hours and cell 
viability was assessed using the MTT assay. At least three independent experiments with six 
replicates were performed per concentration for each compound. 
 
The embryonic stem cell-derived cardiomyocytes are thus more sensitive to diphenhydramine 
and veratridine than the neuro-2a cells. 
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Ca2+ channels 
Figure 4.2C shows that the Ca2+ channel blocker isradipine at concentrations of 20 µM and 
higher caused beating arrests in every exposed EB (EC50 = 15 µM, Tab. 4.1). After exposure to 
up to 30 µM isradipine, all EBs recovered after refreshment of the medium. After exposure to 60 
or 100 μM israpidine, 50% of the EBs recovered after medium refreshment. The other Ca2+ 
channel blocker, verapamil, induced beating arrests at concentrations from 100 nM onwards. 
Where 100 nM of verapamil induced beating arrest in half of the EBs, all EBs stopped beating at 
300 and 1000 nM (EC50 = 100 nM, Tab. 4.1). All EBs recovered at 100 nM, while 50% 
recovered at 300 nM and 600 nM. At concentrations of 1000 nM and higher, the cells did not 
recover anymore (Fig. 4.2D). The WST-1 tests showed that cell viability was not affected by the 
tested concentrations of isradipine or verapamil (Tab. 4.1). 
Figure 4.3C and 4.3D show that in the neuro-2a assay, isradipine up to 100 µM had no effect 
on the cell viability, while verapamil at concentrations of 30 nM and higher induced a decrease 
in cell viability.  
The determined EC50 values show that the embryonic stem cell-derived cardiomyocytes are 
more sensitive for isradipine than neuro-2a cells, and also slightly more sensitive for verapamil 
(Tab. 4.1). 
K+ channels 
None of the K+ channel blockers induced beating arrests of the EBs at non-cytotoxic 
concentrations: amiodarone up to 60 µM, clofilium up to 100 µM and sematilide up to 400 µM 
had no effect on the beating (Fig. 4.2H-I-J). The cell viability was affected by amiodarone but 
not by sematilide according to the results obtained with the WST-1 assay (Tab. 4.1). However, 
higher concentrations of clofilium from 100 µM onwards induced cytotoxicity (WST-1 assay, 
Tab. 4.1), and the resulting beating arrests were thus not due to the K+ channel blockade. In 
accordance with this observation, none of the EBs exposed to high levels of clofilium recovered 
(Fig. 4.2I).  
In the neuro-2a assay, amiodarone and clofilium at and above a concentration of 10 µM 
induced a decrease in cell viability, while sematilide had no effect up to 300 µM (Fig. 4.3G-H-I).  
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The neuro-2a cells are thus more sensitive to amiodarone and clofilium than the embryonic 
stem cell-derived cardiomyocytes, while both cell assays were insensitive for sematilide (Tab. 
4.1). 
Na+/K+-ATPase pump 
Figure 4.2E shows the effects of the Na+/K+-ATPase pump blocker ouabain on the beating of the 
cardiomyocytes. Concentrations up to 100 µM of ouabain did not induce a beating arrest in the 
EBs. At concentrations of 200 µM and higher, ouabain induced a concentration-dependent 
decrease in the percentage of beating cells (EC50 = 257 µM, Tab. 4.1). While most EBs 
recovered from the 300 µM exposure, almost none of the EBs that stopped beating at 600 µM 
recovered after the medium refreshment. It should be mentioned that the beating rates of some 
EBs that did not stop beating after exposure to ouabain (up to 100 µM) were largely increased 
(increased beating frequency not quantified) and this increased beating frequency may also 
reflect neurotoxicity. The Na+/K+-ATPase pump inhibitor digoxin did not affect the beating of 
the cells up to 150 µM (Fig. 4.2F). According to the outcomes of the WST-1 assay, the viability 
of the cardiomyocytes was not affected by ouabain but slightly affected by digoxin at 160 µM 
(Tab. 4.1).  
Ouabain at concentrations of 300 µM and higher induced a decrease in cell viability of neuro-
2a cells and digoxin up to 100 µM did not affect cell viability of neuro-2a cells (Fig. 4.3E and 
4.3F). The two assays thus display a similar sensitivity towards these Na+/K+-ATPase pump 
inhibitors. 
 
Marine biotoxins: Proof of principle 
Figure 4.2G shows the effects of the commercially available Na+ channel blocker STX on the 
beating of cardiomyocytes after 20 hours of exposure. As no beating arrest was observed after a 
1 hour exposure to STX, the EBs were checked every hour for 6 hours and after 20 hours. STX 
only induced a concentration dependent decrease in the beating of the cardiomyocytes after a 
period of 20 hours (EC50 = 3.9 µM, Tab. 4.1). Every EB exposed to concentrations of STX up to 
8 µM recovered, while 80% of them recovered at 16 and 33 µM. TTX up to 60 µM did not alter 
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the beating of cardiomyocytes after an exposure of 24 hours. Neither STX nor TTX had an effect 
on the viability of embryonic stem cell-derived cardiomyocytes (WST-1 assay, Tab. 4.1). 
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Figure 4.4: Effect of the Na+ channel blockers saxitoxin and tetrodotoxin on the viability of 
neuro-2a cells, with (plain line) or without (dashed line) ouabain/veratridine. The cells were 
exposed to ouabain/veratridine and STX or TTX at the same time. The cell viability of the cells 
exposed to ouabain/veratridine alone was about 20%. No cytotoxicity was induced by STX and 
TTX without ouabain/veratridine (dashed line). At least three independent experiments with six 
replicates were performed per concentration for each compound. 
 
Because TTX and veratridine have opposite modes of action, TTX being a Na+ channel 
blocker and veratridine a Na+ channel activator, it was hypothesized that TTX could prevent the 
beating arrest induced by veratridine. Indeed, exposing the cardiomyocytes to 100 µM of 
veratridine for 1 hour, resulting in a beating arrest of all EBs, and then adding TTX to a final 
concentration of 10 µM in each well during an additional hour, resulted in a 100% recovery of 
the beating. In addition, when the cells were pre-treated with 10 µM of TTX during 5 minutes 
and then exposed to 100 µM of veratridine for one hour, none of the EBs stopped beating.  
Without ouabain/veratridine STX and TTX did not induce cytotoxicity in the neuro-2a cells. 
However, when co-incubated with ouabain/veratridine, STX and TTX increased cell viability in 
the neuro-2a cells at and above 10 nM and 3 nM respectively (Fig. 4.4). These data show that the 
neuro-2a cells are more sensitive for these marine biotoxins than cardiomyocytes (Tab. 4.1). 
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Discussion 
Diphenhydramine has been reported to block Na+ channels in neurons at a concentration of 100 
µM [16]. Without a Na+ influx, cardiac cells cannot generate action potentials and 
cardiomyocytes are therefore not able to beat. However, diphenhydramine did not decrease cell 
viability of neuro-2a cells, indicating that either neuro-2a cells do not express the Na+ channel 
subtypes targeted by diphenhydramine or blockade of these channel subtypes does not affect cell 
viability. 
The Na+ channel opener veratridine causes an abnormal entry of Na+ ions followed by a 
secondary increase of the Ca2+ concentration, leading to beating arrests because the Na+ channel 
is unable to close [30]. The sensitivity of the murine embryonic stem cell-derived beating 
cardiomyocytes to veratridine in the present study, i.e. EC50 = 35 µM, is comparable to what has 
been found by Yanagita et al. in 2003, reporting an increase of Na+ influx by veratridine with an 
EC50 of 85 µM in adrenal chromaffin cells [18]. The neuro-2a assays showed a similar sensitivity 
to veratridine, as cell viability was affected with an EC50 of 90 µM. 
Verapamil blocks the L- and T-type Ca2+ channels, while isradipine blocks only the L-type 
Ca2+ channels [31, 32]. In 1994, Keith et al. obtained an EC50 of 19 µM for the synaptosomal 
inhibition of the Ca2+ influx by verapamil in rat cortical neurons [21]. The embryonic stem cell-
derived beating cardiomyocytes represent a more sensitive assay for the detection of verapamil, 
as specific beating arrests were observed for verapamil with an EC50 of 100 nM, which is also 
lower than the one obtained with the neuro-2a assay (EC50 = 190 nM). This indicates that 
embryonic stem cell-derived cardiomyocytes cells are relatively sensitive to verapamil. The EC50 
of isradipine (15 µM) for inducing beating arrests was much higher than that for verapamil, most 
likely because this compound only blocks the L-type Ca2+ channels. Isradipine had no effect on 
the cell viability of neuro-2a cells. Together these data suggest that the neuro-2a cells only 
express the T-type Ca2+ channels, making them sensitive to verapamil in the µM range, but do 
not express the L-type Ca2+ channels, making them insensitive to isradipine. Murine 
cardiomyocytes express both the L- and T-type Ca2+ channels and are therefore sensitive to both 
verapamil and isradipine. 
The K+ channel blockers amiodarone, clofilium and sematilide had no specific inhibiting 
effect on the beating cardiomyocytes. The K+ channel isoforms on the surface of the murine 
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embryonic stem cell-derived cardiomyocytes might be resistant to amiodarone, clofilium and 
sematilide or, in the case of clofilium, the concentrations that elicited beating arrests in the 
murine cardiomyocytes are too close to the concentrations that elicited general cytotoxicity. The 
neuro-2a assay was also insensitive to sematilide, but amiodarone and clofilium were found to 
affect cell viability. 
The Na+/K+-ATPase pump blocker ouabain elicited specific beating arrests and decreased cell 
viability of neuro-2a with a similar sensitivity. The EC50 of 257 µM obtained in the present study 
for ouabain is in line with the findings of Kagiava et al. [25] who showed that ouabain elicited 
neurotoxicity with an EC50 of 370 ± 18 µM in the mouse myelinated sciatic nerve fibres. Digoxin 
had no effect either on the beating (inotropy) of the cardiomyocytes in the EBs or on the cell 
viability of neuro-2a cells. This was expected as digoxin only decreases the function of the 
Na+/K+-ATPase pump and does not block it, However, digoxin appeared to affect beating 
frequency (chronotropy) in the cardiomyocytes which was not included as a read out in our test. 
STX and TTX block Na+ channels and therefore the cells cannot generate action potentials, 
reflecting a mode of action similar to that of diphenhydramine [33]. The incubation time with 
STX required to elicit beating arrests was 20 hours, while for all model neurotoxins tested one 
hour was sufficient. This difference may be due to the fact that STX may only partially block the 
Na+ type channels expressed by the cardiomyocytes, resulting in residual amounts of Na+ ions 
still entering the cells causing shortage of Na+ and effects on the beating process only upon 
prolonged exposure. TTX did not have any effect on the beating up to 60 µM. However, none of 
the cardiomyocytes stopped beating with the combination of 10 µM TTX with 100 µM of the 
Na+ channel opener veratridine, a concentration that stopped the beating of all EBs, indicating 
that co-exposure of the EBs to TTX with veratridine is suitable for detecting TTX. This finding 
is in line with the observation that TTX has been shown to block veratridine-induced effects 
[34]. STX or TTX had no effect on cell viability of neuro-2a cells without addition of 
ouabain/veratridine. However, neuro-2a cells swell and eventually lyse upon exposure to a 
combination of ouabain/veratridine that enhances sodium influx [35]. The Na+ channel blocker 
STX has been shown to protect neuro-2a cells from the action of ouabain/veratridine [14]. Both 
STX and TTX prevented to a certain extent cytotoxicity induced by ouabain/veratridine in neuro-
2a cells. This indicates that the main voltage gated sodium channels present in neuro-2a cells are 
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TTX-sensitive while in the cardiomyocytes these channels are less sensitive to TTX and most 
likely belong to the Nav1.5 channel subtypes [36].  
Certain compounds affect channels that are not expressed on the surface of the murine 
cardiomyocytes such as the N- and R-type Ca2+ channels and will thus not be detected. Since K+ 
channel blockers tested negative their integrity was confirmed by showing their activity towards 
other endpoints. Amiodarone inhibited neuronal activity in rat cortical neurons [37]. Measuring 
effects on the beating rate or on the generation of action potentials as additional parameters, 
using for example multielectrode arrays [38], will most likely result in a more sensitive assay and 
might even result in an assay able to detect a wider range of neurotoxins. Ultimately, a model 
capable of detecting an extensive range of marine neurotoxins shall present a large variety of ion 
channels/pumps as well as neuronal receptors, the principal targets of such toxins. 
In line with the findings from Maltsev et al. (1994) the data provided in the present study 
show that the murine cardiomyocytes have functional Na+, Ca2+ channels and Na+/K+-ATPase 
pump and that beating murine cardiomyocytes can be used as a model to detect specific 
neurotoxic effects of compounds on Na+, Ca2+ channels and the Na+/K+-ATPase pump, but not 
on K+ channels [12]. The inhibition of beatings in the murine cardiomyocytes was shown to be 
reversible and to occur at concentrations below those affecting cytotoxicity, which implies that 
these effects are not due to overall cytotoxicity providing a more specific read out for 
neurotoxicity than the cytotoxicity endpoint as determined in the neuro-2a assay. This is an 
advantage of the cardiomyocytes assay over the neuro-2a cells, providing a way to avoid 
detection of false positives for neurotoxicity. Moreover, for the nine neurotoxic model 
compounds tested, the cardiomyocytes were generally somewhat more sensitive for those 
compounds that affect Na+ and Ca2+ channels, but less sensitive towards the compounds that 
affect K+ channels. The sensitivity of cardiac cells towards neurotoxins suggests that when 
neurotoxins affect ion channels or pumps they will also most likely exhibit cardiotoxicity. 
However, while beating is a more specific endpoint than cytotoxicity, the process behind the 
differentiation of embryonic stem cells into cardiomyocytes is time consuming and labour 
intensive, hampering the implementation of such assay for screening purposes. Nevertheless, 
EC50 values obtained with neuro-2a cells were in the same order of magnitude as that of the 
cardiomyocyte data, which are based on a more specific endpoint than cytotoxicity, and therefore 
seem to validate the cytotoxicity endpoint used in the neuro-2a mouse neuroblastoma assay. In 
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addition, a striking difference in sensitivity was observed for STX and TTX, for which the stem 
cell-derived cardiomyocytes were not as sensitive as the neuroblastoma neuro-2a assay, as the 
EC50 values for STX and TTX were almost three orders of magnitude lower in the neuro-2a 
assay. Sensitivity in the low nanomolar range, as obtained in the neuro-2a assay, is required to 
detect these marine biotoxins in contaminated samples. Beating cardiomyocytes might also not 
be sensitive to neurotoxins with modes of action other than affecting ion channels or pumps as 
for example binding to specific neuronal receptors. 
In summary, this is the first study proposing a cardiac model for neurotoxicity testing. Despite 
its limitations, the assessment of the beating arrest in murine embryonic stem cell-derived 
cardiomyocytes represents an interesting tool for the screening of compounds for their 
neurotoxic properties. Murine stem cell-derived cardiomyocytes provide a sensitive model for 
the detection of specific neurotoxins and the neuroblastoma neuro-2a assay appears to be a more 
promising cell-based assay for the screening of marine biotoxins.  
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